Wolff-Parkinson-White syndrome in cats is a rare heart disease that is characterized by ventricular
With appropriate referral, treatment, and patient education, patients with WPW syndrome can expect to have a normal life expectancy and good quality of life.
Wolf-Hirschhorn syndrome is caused by a deletion of genetic material near the end of the short (p) arm of chromosome 4. This chromosomal change is sometimes written as 4p-.
Wolf-Hirschhorn syndrome (WHS) is a genetic disorder that affects many parts of the body. The major features include a characteristic facial appearance, delayed growth and development, intellectual disability, low muscle tone (hypotonia), and seizures.
Wolff-Parkinson-White (WPW) syndrome is a relatively common heart condition that causes the heart to beat abnormally fast for periods of time. The cause is an extra electrical connection in the heart. This problem with the heart is present at birth (congenital), although symptoms may not develop until later in life.
Patients with WPW syndrome may experience palpitations, dizziness, syncope, congestive heart failure or sudden cardiac death (SCD). In some patients, the first and only manifestation of the disease is SCD.
Low-voltage, high-frequency electrical energy interrupts the extra pathway in your heart. Your doctor threads a catheter into your heart through a vein in your thigh. The treatment cures WPW about 95 percent of the time.
Alström syndrome is a rare condition that was first revealed in the literature in 1959 by Carl-Henry Alström from Sweden (1). The syndrome is an autosomal recessive genetic disorder. The disorder is caused by a mutation to the Alström syndrome 1 (ALMS1) gene and affects many systems in the body (2,3).
Myhre syndrome is an extremely rare inherited disorder that, in theory, affects males and females in equal numbers. Fewer than 100 patients have been reported in the medical literature, but cases are being steadily published.
Myhre syndrome is a rare disorder; its prevalence is unknown. Almost 100 cases have been documented in the medical literature.
WPW is not usually hereditary, that is, it is not usually passed from parents to children. In the normal conduction system, there is only one pathway for electrical signals to pass from the heart's upper chambers — the atria- to the heart's lower chambers — the ventricles. This pathway is called the AV node.
AV node blockers should be avoided in atrial fibrillation and atrial flutter with Wolff Parkinson White syndrome (WPW). In particular, avoid adenosine, diltiazem, verapamil, and other calcium channel blockers and beta-blockers.
If left untreated, WPW syndrome can cause the following problems: Heart failure. Serious arrhythmias, including atrial fibrillation. Cardiac arrest, which can be fatal and is more common in boys and men and in people who have other heart conditions.
Wolff-Parkinson-White syndrome (WPW) is most common in children who are born with a heart condition (congenital heart disease), but it can also occur in those without. Most people experience symptoms between the ages of 30 and 40.
The episodes of fast heartbeats seen in WPW syndrome usually aren't life-threatening, but serious heart problems can occur. Rarely, WPW syndrome may lead to sudden cardiac death in children and young adults.
RPI Deficiency
This is considered to be the rarest disease in the world. Ribose-5-Phosphate Isomerase (RPI), is a crucial enzyme in a metabolic process in the human body. This condition can cause muscle stiffness, seizures, and reduction of white matter in the brain.
A rare developmental defect during embryogenesis characterized by premature closure of metopic sutures and/or other sutures, short stature, and developmental delay.
The estimated incidence of Jacobsen syndrome is 1 in 100,000 newborns. More than 200 affected individuals have been reported.
Leigh syndrome is a rare inherited neurometabolic disorder that affects the central nervous system. This disorder begins in infants between the ages of 3 months and 2 years. Rarely, it can occur in teenagers and adults.
Frequency. Cockayne syndrome is estimated to occur in 2 to 3 per million newborns in the United States and Europe.
High-risk features on clinical evaluation include male sex, WPW pattern detected in the first two decades of life, history of atrial fibrillation (AF), arrhythmic symptoms (especially syncope), congenital heart disease (e.g., Ebstein's anomaly), or familial WPW syndrome.
The WPW pattern is applied to the patient with pre-excitation manifest on an EKG in the absence of symptomatic arrhythmias. The WPW syndrome is applied to the patient with both pre-excitation manifest on an EKG and symptomatic arrhythmias involving the accessory pathway.
The risk of stroke in WPW syndrome is very low (0.7%). Only one clinical factor differs significantly from remaining population, the relatively old age (mean 62 ± 9 years).